Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q1 2018 Earnings Conference Call - Final Transcript

your sales force size, and is there opportunity to expand further just to go deeper into the Chinese market?

Ryan, just to clarify our head count in China, it's probably 35 pre-Codman, 70-plus post-Codman, and we're probably going to be adding 10 plus resources there in 2018, so think of it as exiting 2018 with about 85 total commercial resources in China. But we see China as a best growth market for us. If you've followed the story for the past few years, China has been a market where we've put up 20%-plus growth on a pretty consistent basis, and we're quite excited about the opportunity now with having our combined sales forces coming together and driving growth in that market. And so that's the reason why we've been investing very heavily in China.

But I think as we've dealt with other markets, we don't try to get too far out of our ski tips. I think as we see the growth of the combined portfolio pick up, we primarily cover the coast and so as other provinces and systems develop, yeah, I think this will be a market that we will add. We're big importers as far as products into the market, how we kind of build out that market for larger sustainability is a big part of our strategic plans. But as Glenn said, I think with the structure we have right now, we've got the capabilities for continued high growth coming out of China.

Got it. All right. Thanks for taking the questions, guys.

Yeah. Thank you.

Thank you.

[Operator Closing Remarks]